PubMed=9685856; DOI=10.1111/j.1349-7006.1998.tb03293.x; PMCID=PMC5921857
Juan Emilio Fernandez-Barbero, Jose Prados, Consolacion Melguizo, Nicola Arena, Fabio Malavasi, Luis Alvarez, Antonia Aranega;
Characterization of a new human embryonal rhabdomyosarcoma cell line, RMS-GR.
Jpn. J. Cancer Res. 89:525-532(1998)

PubMed=10470293; DOI=10.1111/j.1349-7006.1999.tb00816.x; PMCID=PMC5926126
Jose Prados, Consolacion Melguizo, Juan Antonio Marchal, Celia Velez, Luis Alvarez, Antonia Aranega;
Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.
Jpn. J. Cancer Res. 90:788-793(1999)

PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458
Ashley R.P. Hinson, Rosanne Jones, Lisa E.S. Crose, Brian C. Belyea, Frederic G. Barr, Corinne Mary Linardic;
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.
Front. Oncol. 3:183.1-183.12(2013)

PubMed=23665679; DOI=10.1038/onc.2013.129
Elizabeth I. Sokolowski, Claire B. Turina, Ken Kikuchi, David M. Langenau, Charles Keller;
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014)